PhosLo Alternatives Compared
PhosLo (calcium acetate) | Calcium acetate | Aluminum hydroxide |
|
---|
PhosLo (calcium acetate) | Calcium acetate | Aluminum hydroxide |
|
|||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Prescription and OTC
Prescribed for Hyperphosphatemia. PhosLo may also be used for purposes not listed in this medication guide. |
Prescription and OTC
Prescribed for Hyperphosphatemia. Calcium acetate may also be used for purposes not listed in this medication guide. |
Prescription and OTC
Prescribed for GERD, Duodenal Ulcer, Erosive Esophagitis, Gastrointestinal Hemorrhage, Hyperphosphatemia, Indigestion, Peptic Ulcer, Stomach Ulcer, Zollinger-Ellison Syndrome. Aluminum hydroxide may... View more |
Related suggestions Popular comparisons
|
|||||||||||||||
More about PhosLo (calcium acetate) | More about Calcium acetate | More about Aluminum hydroxide | ||||||||||||||||
Ratings & Reviews | ||||||||||||||||||
PhosLo has an average rating of 8.0 out of 10 from a total of 2 ratings on Drugs.com. 100% of reviewers reported a positive effect, while 0% reported a negative effect. |
Calcium acetate has an average rating of 5.5 out of 10 from a total of 4 ratings on Drugs.com. 50% of reviewers reported a positive effect, while 50% reported a negative effect. |
Be the first to share your experience with this drug. |
||||||||||||||||
Drug Class | ||||||||||||||||||
Side Effects | ||||||||||||||||||
Generic Availability | ||||||||||||||||||
N/A |
Lower cost generic |
Lower cost generic |
||||||||||||||||
Pricing and Coupons * Prices are without insurance | ||||||||||||||||||
We could not find an exact match for this medicine. Try searching the Price Guide directly. |
View all Calcium acetate prices |
View all Aluminum hydroxide prices |
||||||||||||||||
Dosage Forms Available | ||||||||||||||||||
|
|
|
||||||||||||||||
Brand Names | ||||||||||||||||||
Other calcium acetate brands include: Calphron, Phoslyra | Calphron, PhosLo, Phoslyra | Aloh-Gel, Alternagel, Alu-Cap, Alu-Tab, Amphojel, Dialume | ||||||||||||||||
Half Life The half-life of a drug is the time taken for the plasma concentration of a drug to reduce to half its original value. | ||||||||||||||||||
N/A |
N/A |
N/A |
||||||||||||||||
CSA Schedule ** View glossary of terms | ||||||||||||||||||
Not a controlled drug
Is not subject to the Controlled Substances Act. |
Not a controlled drug
Is not subject to the Controlled Substances Act. |
Not a controlled drug
Is not subject to the Controlled Substances Act. |
||||||||||||||||
Pregnancy Category | ||||||||||||||||||
Category C
Risk cannot be ruled out
See the full pregnancy warnings document. |
Category C
Risk cannot be ruled out
See the full pregnancy warnings document. |
Category N
Not classified
See the full pregnancy warnings document. |
||||||||||||||||
Drug Interactions | ||||||||||||||||||
A total of 88 drugs are known to interact with PhosLo:
|
A total of 88 drugs are known to interact with Calcium acetate:
|
A total of 238 drugs are known to interact with Aluminum hydroxide:
|
||||||||||||||||
Alcohol/Food/Lifestyle Interactions | ||||||||||||||||||
No known alcohol/food interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
No known alcohol/food interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
|
||||||||||||||||
Disease Interactions | ||||||||||||||||||
First Approval Date | ||||||||||||||||||
December 10, 1990 |
December 10, 1990 |
N/A |
||||||||||||||||
WADA Class View World Anti-Doping Agency classifications. | ||||||||||||||||||
N/A |
N/A |
N/A |
||||||||||||||||
More Information | ||||||||||||||||||
Patient resources | ||||||||||||||||||
Professional Resources | ||||||||||||||||||
N/A |
||||||||||||||||||
Related Treatment Guide | ||||||||||||||||||
** The Controlled Substances Act (CSA) schedule information displayed applies to substances regulated under federal law. There may be variations in CSA schedules between individual states.
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.